Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-02-13
Taubert Jennifer L Files Johnson & Johnson (JNJ) Form 4 - February 13, 2026
Taubert Jennifer L traded 47.9K JNJ shares worth $3.8M in this Form 4 filing, reported to the SEC on 2026-02-13.
- Insider
- Taubert Jennifer L
- Issuer
- Johnson & Johnson JNJ · NYSE
- Filed
- Period
- 2026-02-13
- Accession
- 0000200406-26-000037
- Source
- Official filing on sec.gov ↗
Transactions (8)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Taubert Jennifer L | 2026-02-15 | Sell | 945 | $243.45 | $230.1K | Direct |
| Taubert Jennifer L | 2026-02-15 | Buy | 1.6K | $0.00 | $0.00 | Direct |
| Taubert Jennifer L | 2026-02-15 | Sell | 816 | $243.45 | $198.7K | Direct |
| Taubert Jennifer L | 2026-02-15 | Buy | 1.8K | $0.00 | $0.00 | Direct |
| Taubert Jennifer L | 2026-02-13 | Buy | 1.3K | $0.00 | $0.00 | Direct |
| Taubert Jennifer L | 2026-02-13 | Sell | 409 | $244.55 | $100.0K | Direct |
| Taubert Jennifer L | 2026-02-13 | Buy | 27.4K | $0.00 | $0.00 | Direct |
| Taubert Jennifer L | 2026-02-13 | Sell | 13.5K | $244.55 | $3.3M | Direct |
| Net change | +16.4K | −$3.8M | ||||
About Johnson & Johnson
Johnson & Johnson is a multinational corporation engaged in the research, development, production, and sale of a broad range of healthcare products. Primarily known for its pharmaceuticals, medical devices, and consumer health products, Johnson & Johnson has a significant presence in the global healthcare industry. It develops medications for a variety of fields such as immunology, oncology, neurology, infectious diseases, and vaccines. The company also produces a wide array of medical devices for surgery, orthopedics, and cardiovascular health. In addition to pharmaceuticals, Johnson & Johnson is renowned for its consumer health products, including baby care, skin and hair care, wound care, and over-the-counter pharmaceuticals, with well-recognized brands like Band-Aid, Tylenol, and Neutrogena. Operating globally, the corporation's extensive portfolio and commitment to healthcare innovation make it a pivotal player in the industry, ensuring it remains influential in addressing worldwide health challenges and advancing medical technology.
Track JNJ insider activity
Get alerted when Johnson & Johnson executives buy or sell their shares.